The Bermuda Triangle may not be the biggest mystery of the Atlantic. In a new study published in the journal Geophysical Research Letters, scientists believe they have discovered the reason why ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Shareholders were extremely pleased by the biotech's latest news from the lab. This concerned its pipeline weight-loss drug aleniglipron. Structure, which concentrates on metabolic diseases with a ...

Dec 8 (Reuters) - Structure Therapeutics (GPCR.O), opens new tab said on Monday its obesity pill showed weight loss of up to 11.3% after 36 weeks of treatment in a mid-stage study, driving the company ...

Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...

The article examines the problem of training load periodization for professional football players under the conditions of an increasingly congested competition calendar and heightened injury risks.

This study examined the impact of a volleyball-specific periodization program monitored with sRPE on adolescent female athletes (13 - 16 years). Across three cohorts (n = 58), internal load increased ...

1 Sport Training Laboratory, University of Castilla-La Mancha, Toledo, Spain 2 Universidad Internacional de La Rioja, Facultad Ciencias de la Salud y Escuela de Doctorado, Logroño, Spain Introduction: ...

Strong financial position with cash, cash equivalents and short-term investments of $786.5 million as of June 30, 2025 expected to fund projected operations and key clinical milestones through at ...